Volume 82, Issue 7, Pages (October 2012)

Slides:



Advertisements
Similar presentations
Melamine toxicity: one more culprit in calcium kidney lithiasis
Advertisements

Michael D. Gautreaux, Barry I. Freedman  Kidney International 
Renal manifestations in Fabry disease and therapeutic options
Propofol-related green urine
Anemia management in chronic kidney disease
Mitchell H. Rosner, W. Kline Bolton  Kidney International 
Stem cells for kidney repair: useful tool for acute renal failure?
Ming-Tso Yan, Ming-Ju Wu, Po-Jen Hsaio, Shih-Hua Lin 
ESA and iron therapy in chronic kidney disease: a balance between patient safety and hemoglobin target  Szu-Chun Hung, Der-Cherng Tarng  Kidney International 
Status of chronic kidney disease prevention programs: International Federation of Kidney Foundation Members 2005/2007  Joanna M. Smith, Susan A. Mott,
Reassessment of the care of the patient with chronic kidney disease
Volume 80, Issue 10, Pages (November 2011)
John P. Middleton, Patrick H. Pun  Kidney International 
Jeffrey C. Fink, Glenn M. Chertow  Kidney International 
Comorbidity and confounding in end-stage renal disease
Volume 74, Issue 3, Pages (August 2008)
The new role of calcimimetics as vasculotropic agents
The contentious ontogeny of fibrosis in the kidney
Volume 70, Issue 11, Pages (December 2006)
Nephrology Crosswords: Hemodialysis
Volume 86, Issue 2, Pages (August 2014)
Use of vitamin D in chronic kidney disease patients
Volume 87, Issue 2, Pages (February 2015)
Harnessing regulatory T cells for therapeutic purposes
Junichiro J. Kazama, Masafumi Fukagawa  Kidney International 
Bisphosphonate safety and efficacy in chronic kidney disease
Nephrology Crossword: History of nephrology
Kenar D. Jhaveri, Steven Fishbane  Kidney International 
Melamine toxicity: one more culprit in calcium kidney lithiasis
Volume 84, Issue 4, Pages (October 2013)
Volume 76, Issue 6, Pages (September 2009)
Volume 85, Issue 3, Pages (March 2014)
Novel phosphate binders: plus ça change, plus c’est la même chose
A physician's perseverance uncovers problems in a key nephrology study
Mesenchymal Stem Cells for Bone Repair and Metabolic Bone Diseases
Extracorporeal therapy in sepsis: are we there yet?
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Tilman B. Drüeke, Ziad A. Massy  Kidney International 
Volume 74, Issue 8, Pages (October 2008)
Volume 87, Issue 3, Pages (March 2015)
Nephrology Crossword: Peritoneal Dialysis
Volume 56, Issue 4, Pages (October 1999)
Nephrology Crossword: Glomerulonephritis
Unilateral renal cystic disease
A man with a hole in his penis
Volume 78, Issue 8, Pages (October 2010)
Volume 73, Issue 9, Pages (May 2008)
Will there be an epidemic of HIV-related chronic kidney disease in sub-Saharan Africa? Too soon to tell  Kara K. Wools-Kaloustian, Samir K. Gupta  Kidney.
Vitamin D in chronic kidney disease: is the jury in?
Volume 82, Issue 9, Pages (November 2012)
The treatment of acute interstitial nephritis: More data at last
Organ transplantation goes to the movies
Does equal care give equal outcomes?
Volume 72, Issue 3, Pages (August 2007)
Volume 83, Issue 5, Pages (May 2013)
Volume 83, Issue 4, Pages (April 2013)
David A. Ferenbach, David C. Kluth, Jeremy Hughes  Kidney International 
Volume 70, Issue 3, Pages (August 2006)
Tobias Breidthardt, Alexandre Mebazaa, Christian E. Mueller 
Volume 75, Issue 7, Pages (April 2009)
Membranous nephropathy: recent travels and new roads ahead
Hisataka Kobayashi, Peter L. Choyke  Kidney International 
The international realities of live donor kidney transplantation
Volume 70, Issue 10, Pages (November 2006)
Transition of Endothelium to Cartilage and Bone
Volume 74, Issue 10, Pages (November 2008)
Volume 163, Issue 2, (October 2015)
Volume 76, Issue 2, Pages (July 2009)
Ronen Levi, Justin Silver  Kidney International 
Presentation transcript:

Volume 82, Issue 7, Pages 731-733 (October 2012) Adipose tissue–derived mesenchymal stem cells: a fat chance of curing kidney disease?  Fangming Lin  Kidney International  Volume 82, Issue 7, Pages 731-733 (October 2012) DOI: 10.1038/ki.2012.158 Copyright © 2012 International Society of Nephrology Terms and Conditions

Figure 1 Isolation, characterization, and potential therapeutic use of mesenchymal stem cells. (a) Adipose tissue–derived stem cells can be isolated by culture expansion of plastic-adherent cells followed by cell characterization. Note that cells in culture are heterogeneous. They include mesenchymal stem cells, stromal cells, and fibroblasts. (b) Mesenchymal stem cells are characterized by their properties of self-renewal and differentiation into adipocytes, chondroblasts, and osteoblasts. The cells could potentially be used to treat diseases by providing immunomodulation, anti-inflammatory actions, and cell replacement as well as delivering therapeutic agents. Kidney International 2012 82, 731-733DOI: (10.1038/ki.2012.158) Copyright © 2012 International Society of Nephrology Terms and Conditions